These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 665710)

  • 1. Clinical experience with a simple screening test for Cushing's syndrome combining the determination of plasma cortisol circadian rhythm with the overnight dexamethasone suppression test.
    Reschini E; Giustina G
    Am J Med Sci; 1978; 275(1):33-42. PubMed ID: 665710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.
    Montwill J; Igoe D; McKenna TJ
    Steroids; 1994 May; 59(5):296-8. PubMed ID: 8073441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome.
    Newell-Price J; Trainer P; Perry L; Wass J; Grossman A; Besser M
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):545-50. PubMed ID: 8548938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overnight dexamethasone pre-treatment improves the performance of the lysine-vasopressin test in the diagnosis of Cushing's syndrome.
    Contreras P; Araya V
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):703-10. PubMed ID: 8759183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cushing's syndrome: a review of diagnostic tests.
    Crapo L
    Metabolism; 1979 Sep; 28(9):955-77. PubMed ID: 225638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overnight dexamethasone suppression test: comparison of plasma and salivary cortisol measurement for the screening of Cushing's syndrome.
    Barrou Z; Guiban D; Maroufi A; Fournier C; Dugué MA; Luton JP; Thomopoulos P
    Eur J Endocrinol; 1996 Jan; 134(1):93-6. PubMed ID: 8590965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: limitations in patients with mild and/or episodic hypercortisolism.
    Friedman TC
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):356-60. PubMed ID: 16915537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose four hour dexamethasone suppression test in normal men and its application for the diagnosis of Cushing's syndrome.
    Nishida S; Matsumura S; Horino M; Oyama H; Tenku A
    Steroids; 1976 Sep; 28(3):411-21. PubMed ID: 982498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese.
    Ness-Abramof R; Nabriski D; Apovian CM; Niven M; Weiss E; Shapiro MS; Shenkman L
    Obes Res; 2002 Dec; 10(12):1217-21. PubMed ID: 12490665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
    J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cushing's syndrome. Screening methods in hospitalized patients.
    Dunlap NE; Grizzle WE; Siegel AL
    Arch Pathol Lab Med; 1985 Mar; 109(3):222-9. PubMed ID: 3838451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-Dose and Standard Overnight and Low Dose-Two Day Dexamethasone Suppression Tests in Patients with Mild and/or Episodic Hypercortisolism.
    Mojtahedzadeh M; Shaesteh N; Haykani M; Tran JLA; Mangubat M; Shahinian HK; Nachnani R; Zopey M; Saidian J; Thomas A; Lee ML; McCutcheon IE; Friedman TC
    Horm Metab Res; 2018 Jun; 50(6):453-461. PubMed ID: 29719879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of Cushing's syndrome: re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group.
    Görges R; Knappe G; Gerl H; Ventz M; Stahl F
    J Endocrinol Invest; 1999 Apr; 22(4):241-9. PubMed ID: 10342356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests.
    Alwani RA; Schmit Jongbloed LW; de Jong FH; van der Lely AJ; de Herder WW; Feelders RA
    Eur J Endocrinol; 2014 Apr; 170(4):477-86. PubMed ID: 24394725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late-night salivary cortisol as a screening test for Cushing's syndrome.
    Raff H; Raff JL; Findling JW
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2681-6. PubMed ID: 9709931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
    Lee TI; Lin SY; Won JG; Tang KT; Jap TS; Kwok CF; Lin HD
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overnight (1 mg) dexamethasone suppression testing reliably distinguishes non-cushingoid obesity from Cushing's syndrome.
    Fok AC; Tan KT; Jacob E; Sum CF
    Steroids; 1991 Nov; 56(11):549-51. PubMed ID: 1814020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
    JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.